Immunic to participate in scientific and industry conferences in november

New york , oct. 26, 2023 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and industry conferences in november: november 2-5: association of european coeliac societies (aoecs) 35th general assembly conference 2023 . franziska buriÁnek, m.d.
IMUX Ratings Summary
IMUX Quant Ranking